Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Givlaari ema marketing authorisation date?

See the DrugPatentWatch profile for Givlaari

What is the marketing authorisation (EMA) date for Givlaari?

The provided information does not include the European Medicines Agency (EMA) marketing authorisation date for Givlaari, so I can’t state the exact authorisation date from the available data.

What I need to give you the exact date

If you share the EMA document link, the product page link, or the authorisation press release text you’re looking at, I can extract the exact “authorisation date” (and distinguish it from related dates like submission date, CHMP opinion date, or European Commission approval date).

Where this date usually appears on EMA sources

On EMA-related pages or documents, the date you want is typically shown as the “marketing authorisation date” on the product’s official authorisation record, which is distinct from other milestones such as the CHMP opinion and application dates.

Quick check: are you looking for the EMA authorisation or the European Commission approval date?

Some users refer to the “EMA marketing authorisation date” but actually mean the date the European Commission granted the marketing authorisation for the product. If you confirm which one you need, I’ll report the correct date.

Sources: none provided in the prompt.



Other Questions About Givlaari :

What are the side effects of the drug Givlaari?